Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer

Cellular and Molecular Life Sciences

Volumn 59, Issue 8, 2002, Pages 1406-1412

  Zaffaroni, N ^a   Pennati, M ^a   Colella, G ^a   Perego, P ^a   Supino, R ^a   Gatti, L ^a   Pilotti, S ^a   Zunino, F ^a   Daidone, M G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Apoptosis; Cisplatin; Ovarian cancer; Survivin; Taxol

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; COMPLEMENTARY DNA; DOCETAXEL; GLUTATHIONE; MESSENGER RNA; OXALIPLATIN; PACLITAXEL; PLATINUM DERIVATIVE; PROTEIN P53; SURVIVIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GRADING; CELL GROWTH; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GROWTH INHIBITION; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CHROMOSOMAL PROTEINS, NON-HISTONE; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IN SITU NICK-END LABELING; MICROTUBULE-ASSOCIATED PROTEINS; MUTATION; NEOPLASM PROTEINS; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; PACLITAXEL; PHOSPHORYLATION; PHOSPHOTRANSFERASES; TAXOIDS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036693488     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8518-3     Document Type: Article

References (24)

1. BAX protein expression and clinical outcome in epithelial ovarian cancer
2. P53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma
3. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
4. Survivin apoptosis: An interloper between cell death and cell proliferation in cancer
5. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
6. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7
7. The survivin saga goes in vivo
8. The cancer anti-apoptosis mouse survivin gene: Characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression
9. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin
10. Control of apoptosis and mitotic spindle checkpoint by survivin
11. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement
12. Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cancer cells
13. A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system
14. Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cells: Interference with cell cyle progression and induction of apoptosis
15. High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer
16. Developmentally regulated expression of the novel anti-apoptosis gene survivin in human and mouse differentiation
17. IAP-family protein survivin inhibits caspase activity and apoptosis induced by fas (CD95), bax and anticancer drugs
18. The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancers in a prospective randomized treatment protocol
19. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells
20. Cancer gene therapy using a survivin mutant adenovirus
21. Inhibition of melanoma tumor growth in vivo by survivin targeting
22. Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis
23. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway
24. A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma